ARRANGEMENT FOR CONTROLLING PLACING OF CEMENT BRIDGES IN WELLS,申请号SU19823472486-传众专利搜索

首页产品黄页商标征信

会员服务注册登录

法人/股东/高管

发明名称	ARRANGEMENT FOR CONTROLLING PLACING OF CEMENT BRIDGES IN WELLS
摘要
申请公布号	SU1190002(A1)	申请公布日期	1985.11.07
申请号	SU19823472486	申请日期	1982.05.18
申请人	NOVIKOV YURIJ M,SU;TERSHAK BOGDAN A,SU;PAZYAK NIKOLAJ M,SU;FEDYANIN ALEKSANDR V,SU	发明人	NOVIKOV YURIJ M,SU;TERSHAK BOGDAN A,SU;PAZYAK NIKOLAJ M,SU;FEDYANIN ALEKSANDR V,SU
分类号	E21B33/14;(IPC1-7):E21B33/14	主分类号	E21B33/14
代理机构		代理人
主权项
地址

您可能感兴趣的专利

CARBON NANOTUBES CONFORMALLY COATED WITH DIAMOND NANOCRYSTALS OR SILICON CARBIDE, METHODS OF MAKING THE SAME AND METHODS OF THEIR USE

PROFILE SECTION MOLDED BY MULTI-INJECTION MOLDING AND FORMING A SEAL OR A MOLDING FOR THE BODY OF A MOTOR VEHICLE, AND METHOD FOR MANUFACTURING SAME

PANEL WITH FIRE BARRIER

Method of Making Reinforced Composite Articles with Reduced Fiber Content in Local Areas and Articles Made by the Method

VACUUM GLASS INCLUDING PILLARS HAVING DIFFERENT ARRANGEMENT DISTANCES, AND METHOD FOR MANUFACTURING SAME

NANO-TRIBOLOGY COMPOSITIONS AND RELATED METHODS INCLUDING MOLECULAR NANO-SHEETS

CARTRIDGE POSITIONING SYSTEM

PROCESS FOR FABRICATING LEAF TEA PRODUCTS

COPPER/ZINC SUPEROXIDE DISMUTASE (SOD) FORMULATION FOR THE TREATMENT OF TRAUMAS INCLUDING AMYOTROPIC LATERAL SCLEROSIS

NANOPARTICULATE COMPOSITIONS OF TUBULIN INHIBITOR COMPOUNDS

Highly Bioavailable Composition Containing Eprosartan - Poloxamer Complex or 2-(7-Chloro-5-Methyl-4-Oxo-3-Phenyl-4,5-Dihydro-3H-Pyridazine (4,5-b)Indol-1-yl)-N,N-Dimethylacetamide - Poloxamer Complex

MULTILAYERED POLYELECTROLYTE-BASED CAPSULES FOR CELL ENCAPSULATION AND DELIVERY OF THERAPEUTIC COMPOSITIONS

INTRAPERITONEALLY-ADMINISTERED NANOCARRIERS THAT RELEASE THEIR THERAPEUTIC LOAD BASED ON THE INFLAMMATORY ENVIRONMENT OF CANCERS

METHOD FOR PREVENTING AND/OR TREATING PERIODONTAL DISEASE

BONE FIBER COMPOSITIONS

Lyme Disease Vaccine

PROTEIN-BASED STREPTOCOCCUS PNEUMONIAE VACCINES

HUMAN IL-23 ANTIGEN BINDING PROTEINS

SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TREATMENT OF MEDICAL DISORDERS

COMBINATION THERAPY USING P53 ACTIVATOR AND C-MET INHIBITOR